MANNING Cefaclor sustained-release capsules 0.125gx6capsulesx2plates/box
$4.06 / Parcel$6.09 Min.order:1
Super Low Price
0.125gx6 capsulesx2 plates/box National Drug Approval No. H20000695

Support Payment Term:

HSBC Hong Kong

paypal

Alibaba Pay

Western Union

USD

EUR

GBP

SGD

HKD

CNH

CAD

MXN

BRL

JPY

THB

MOP

AUD

NZD

PLN

CZK

HUF

RON

CHF

SEK

NOK

DKK

TRY

AED

SAR

ILS

ZAR

$0.00

Quantity

0.125gx6capsulesx2plates/box 

National Drug Approval No. H20000695

The main ingredient of this product is:Cefaclor. The chemical name is (6R,7R)-7[(R)-2-Amino-2-phenylacetamido]-3-chloro-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic acid monohydrate. The chemical structure formula is as follows: Molecule

【Indications】This product is indicated for the following mild and moderate infections caused by sensitive bacteria: 1. Acute exacerbation of chronic bronchitis caused by Haemophilus influenzae (only non-β-lactamase-producing bacteria), Moraxella catarrhalis (including β-lactamase-producing bacteria), and S. pneumoniae; 2. Acute bronchitis secondary infection caused by Haemophilus influenzae (only non-β-lactamase-producing bacteria), Moraxella catarrhalis (including β-lactamase-producing bacteria), and S. pneumoniae; 3. Pharyngitis, tonsillitis caused by Streptococcus pyogenes; 4. Secondary infections of acute bronchitis caused by Streptococcus pneumoniae; 3. Pharyngitis and tonsillitis caused by Streptococcus pyogenes; 4. Uncomplicated infections of the skin and soft tissues of the skin caused by Staphylococcus aureus (methicillin-susceptible strains).